Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

WBD vs VTRS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VTRS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

VTRS Overall Winner 6-Pillar Tally: WBD 1 – 5 VTRS Matrix Metrics: WBD 2 – 8 VTRS

As of Nov 20, 2026, Viatris Inc. (VTRS) is the stronger overall head-to-head candidate over Warner Bros. Discovery, Inc. Series A (WBD) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WBD carries a Unified Composite Score of 44.2/100 (HOLD) at $30.95 (N/M Forward P/E, 5.1% operating margin), whereas VTRS carries 52.2/100 (HOLD) at $19.63 (7.1x Forward P/E, 11.5% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WBD vs VTRS
WBD NASDAQ
Warner Bros. Discovery, Inc. Series A Common Stock
Cable & Other Pay Television Services
$30.95
+0.03% 1D
Market Cap $77.6B
TTM Revenue $36.1B
Forward P/E N/M
Beta / 30D Vol 0.47β · 39% Vol
Unified Composite Score
44.2 / 100 HOLD
Tech 24.0 Fund 44.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.5% over 20 days), RSI 75
RSI-14: 75.1 · SMA20: $29.61 · SMA50: $28.33
VTRS NASDAQ Head-to-Head Winner
Viatris Inc. Common Stock
Pharmaceutical Preparations
$19.63
-1.26% 1D
Market Cap $22.8B
TTM Revenue $14.7B
Forward P/E 7.1x
Beta / 30D Vol 0.55β · 31% Vol
Unified Composite Score
52.2 / 100 HOLD
Tech 37.0 Fund 53.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.4% over 20 days), RSI 52
RSI-14: 52.3 · SMA20: $19.73 · SMA50: $18.47

6-Pillar Scorecard Institutional Category Breakdown (WBD 1 – 5 VTRS)

Columns: Metric · WBD · VTRS
1. Valuation Multiples VTRS
Forward P/E N/M 7.1x
Trailing P/E N/M 7.4x
PEG Ratio N/M 3.69x
EV / Revenue 2.9x 2.3x
2. Growth & Scale VTRS
Revenue Growth (YoY) -11.2% -0.3%
Earnings Growth (YoY) -90.6% -70.6%
TTM Revenue (USD) $36.1B $14.7B
Market Cap $77.6B $22.8B
3. Profitability & Quality VTRS
Gross Margin 47.8% 41.1%
Operating Margin 5.1% 11.5%
Net Profit Margin -8.8% -4.1%
Return on Equity (ROE) -8.8% -4.2%
4. Balance Sheet & Cash Flow VTRS
Cash Generation (TTM) $2.18B $1.98B
Cash Flow Margin 6.0% 13.4%
Net Cash / Leverage $28.7B Net Debt (0.98x D/E) $11.8B Net Debt (0.99x D/E)
Dividend Yield None (0.00%) 2.37%
5. Options & Positioning VTRS
Options Structure Phase UNCLASSIFIED BREAKOUT
Current IV / %ile 1.3% (1st %ile) 31.9% (42nd %ile)
Put/Call OI Skew 1.33x (Put-Skewed) 0.24x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat WBD
OpEx & R&D Intensity 42.7% of Rev ($15.4B) 29.6% of Rev ($4.36B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Entertainment Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WBD (2) vs VTRS (8)
Institutional Metric WBD VTRS Criterion Row Edge
Market Capitalization
Scale
$77.6B $22.8B Larger Scale WBD
Trailing P/E Ratio
Valuation
N/M 7.4x Lower Multiple VTRS
Forward P/E Ratio
Valuation
N/M 7.1x Lower Multiple VTRS
Revenue Growth (YoY)
Growth
-11.2% -0.3% Higher Growth VTRS
Operating Margin (TTM)
Profitability
5.1% 11.5% Higher Margin VTRS
Net Profit Margin
Profitability
-8.8% -4.1% Higher Margin VTRS
Return on Equity (ROE)
Capital Efficiency
-8.8% -4.2% Higher ROE VTRS
52-Week Range Position
Momentum
100% ($17–$31) 86% ($10–$21) Stronger Trend WBD
Beta / 30D Volatility
Risk Regime
0.47β · 39% Vol 0.55β · 31% Vol Lower Realized Risk VTRS
Unified Institutional Score
Composite Signal
44.2 / 100 (HOLD) 52.2 / 100 (HOLD) Higher Composite VTRS
Trailing 12M Revenue (USD)
Operating Scale
$36.1B $14.7B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.8% 41.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.9x EV/Rev 3.69x PEG · 2.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$2.18B ($28.7B Net Debt (0.98x D/E)) $1.98B ($11.8B Net Debt (0.99x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon WBD +5.08 pp
WBD: +9.09% · VTRS: +4.01%
3M Horizon WBD +14.6 pp
WBD: +18.49% · VTRS: +3.89%
6M Horizon VTRS +18.48 pp
WBD: +12.91% · VTRS: +31.39%
1Y Horizon VTRS +34.41 pp
WBD: +34.04% · VTRS: +68.45%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period WBD Revenue VTRS Revenue WBD Op. Margin VTRS Op. Margin Margin Leader
FY2018 $10.6B $11.3B 18.3% 8.0% WBD
FY2019 $11.1B $11.4B 27.0% 6.3% WBD
FY2020 $10.7B $11.8B 23.6% -1.8% WBD
FY2021 $12.2B $17.8B 16.5% -0.2% WBD
FY2022 $33.8B $16.2B -21.8% 10.0% VTRS
FY2023 $41.3B $15.4B -3.7% 5.0% VTRS
FY2024 $39.3B $14.7B -25.5% 0.1% VTRS
FY2025 $37.3B $14.2B 2.0% -18.7% WBD

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WBD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 1.3%
IV Percentile 1st %ile
Put/Call OI Skew 1.33x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact WBD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VTRS BREAKOUT
137d in phase · OBV DISTRIBUTION
Current IV 31.9%
IV Percentile 42nd %ile
Put/Call OI Skew 0.24x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact VTRS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $20.74 · IV 31.3%

VTRS Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($2,074)

Compare $2,074 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 31.3% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $21 / $22 Bull Call Spread

Buy 2x $21C · Sell 2x $22C · 32d

Net Entry $78 Debit
T+5d @ +5% Move +$42 (+54%)
Max Risk / Buffer $78 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Jan 15 '27 $19 / $17 Bull Put Spread

Sell 2x $19P · Buy 2x $17P · 60d

Net Entry $80 Credit
Max Credit / Yield +$80 (+25.0% RoM)
Max Risk / Buffer -10.3% Cushion ($320 Mgn)
5d Edge & Liquidity 76% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq C

Dec 18 $21 / $20 Bear Put Spread

Buy 2x $21P · Sell 2x $20P · 32d

Net Entry $70 Debit
T+5d @ -5% Drop +$49 (+70%)
Max Risk / Buffer $70 Capped
5d Edge & Liquidity 1.1x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WBD Moat Profile Cyclical / Execution-Driven Positioning
Entertainment Operator
Competes within the Entertainment value chain with $77.6B market capitalization and 5.1% operating margin.
OpEx & R&D Reinvestment 42.7% of Rev ($15.4B)
90D Engineering Disclosures 0 Published
VTRS Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $22.8B market capitalization and 11.5% operating margin.
OpEx & R&D Reinvestment 29.6% of Rev ($4.36B)
90D Engineering Disclosures 0 Published

Investor FAQ WBD vs VTRS Key Questions & Quantitative Answers

As of Nov 20, 2026, Viatris Inc. (VTRS) is the stronger overall head-to-head candidate over Warner Bros. Discovery, Inc. Series A (WBD) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). WBD carries a Unified Composite Score of 44.2/100 (HOLD) at $30.95 (N/M Forward P/E, 5.1% operating margin), whereas VTRS carries 52.2/100 (HOLD) at $19.63 (7.1x Forward P/E, 11.5% operating margin). Technically, WBD sits in a Markup phase (RSI 75.1, UNCLASSIFIED options structure) and VTRS sits in a Markup phase (RSI 52.3, BREAKOUT options structure).

VTRS leads the Growth & Scale pillar: WBD posts -11.2% YoY revenue growth and -90.6% YoY earnings growth on $36.1B TTM revenue (47.8% gross margin, 5.1% operating margin), compared with VTRS at -0.3% YoY revenue growth and -70.6% YoY earnings growth on $14.7B TTM revenue (41.1% gross margin, 11.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), WBD cumulative revenue shifted +253.6% while VTRS shifted +26.4%. In operating R&D and SG&A reinvestment, WBD deploys 42.7% of Rev ($15.4B) (0 90-day corporate R&D disclosures) versus 29.6% of Rev ($4.36B) (0 disclosures) for VTRS.

VTRS screens cheaper on headline valuation multiples. WBD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.9x EV/Revenue (6.0% FCF margin), whereas VTRS trades at 7.1x Forward P/E, 7.4x Trailing P/E, 3.69x PEG, and 2.3x EV/Revenue (13.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WBD (-8.8% ROE) versus VTRS (-4.2% ROE) capital efficiency.

In options market volatility and institutional positioning, WBD carries 1.3% implied volatility (1st %ile, Compressed (<25th %ile)), a 1.33x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 39% Vol realized risk). By comparison, VTRS carries 31.9% implied volatility (42nd %ile, Balanced (25th–60th %ile)), a 0.24x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKOUT options structure phase (0.55β · 31% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.